Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Germany

European Innovation Council · Running

STAAART SmarT Abdominal Aortic AneuRysm Treatment World's first device-based treatment for small abdominal aortic aneurysms based on revolutionary new treatment paradigm

Coordinator
Angiolutions GmbH, Germany
Runs
1 January 2024 to 31 December 2025
Status
Running
EU funding
€2.5m
Total cost
€4.0m
Partners
1 organisations in 1 countries
Type
European Innovation Council
Grant agreement
190150530

What the project is doing

In the project's own words, from its summary on CORDIS.

The Angiolutions device is a first-of-its-kind device stopping the life-threatening progression of small abdominal aortic aneurysm (AAA) – a pathological dilation of the aorta. Angiolutions’ award-winning & patent-protected solution leverages a fundamentally new understanding of AAA growth discovered by the founders at Stanford University. They showed that stiffness gradients between the compliant (healthy) aorta and the adjacent stiff (diseased) aneurysm serve as a motor for AAA growth.

Based on this principle & together with key physicians, we developed a minimally-invasive, non-active aortic implant (class III). The nitinol-based device is positioned adjacent to the aneurysm sack via simple, catheter-based implantation. It is specifically designed to focally increase aortic stiffness in the compliant AAA neck region, thereby reducing stiffness gradients towards the stiff AAA sack that drive aneurysm growth.

Hereby, we achieve a fast, low-risk, size-stabilizing treatment of small AAA.

Topics

Who is involved

OrganisationCityCountryRole
Angiolutions GmbHHannoverGermanyCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI